Eden Research plc Publication of Report and Accounts (8766D)
July 01 2021 - 7:19AM
UK Regulatory
TIDMEDEN
RNS Number : 8766D
Eden Research plc
01 July 2021
1 July 2021
Eden Research Plc
("Eden" or "Company")
Publication of Report and Accounts
Eden Research plc (AIM: EDEN), the AIM-quoted company focused on
sustainable biopesticides and plastic-free formulation technology
for use in the global crop protection, animal health and consumer
products industries, announces that its report and accounts
containing the final audited accounts for the year ended 31
December 2020 ("2020 Report and Accounts") are now available on the
Company's website:
https://www.edenresearch.com/investors/reports_and_presentations
Hard copies of the 2020 Report and Accounts will be sent to
those shareholders who have requested them in early July, in
accordance with AIM Rule 20.
A General Meeting ("GM") will be convened in due course to deal
with the formal business of laying out the 2020 Report and Accounts
before shareholders, as required by the Companies Act.
For further information contact:
www.edenresearch.com
Eden Research plc
Sean Smith
Alex Abrey 01285 359 555
Cenkos Securities plc (Nominated advisor
and broker)
Giles Balleny / Camilla Hume/ Mark Connelly
(corporate finance)
Michael Johnson (sales) 020 7397 8900
Hawthorn Advisors (Financial PR)
Lorna Cobbett / Victoria Ainsworth eden@hawthornadvisors.com
Notes to Editors:
Eden Research is an AIM quoted company that develops and
supplies breakthrough biopesticide products and natural,
plastic-free microencapsulation technologies to the global crop
protection, animal health and consumer products industries.
Eden's Sustaine(R) encapsulation technology is used to harness
the biocidal efficacy of naturally occurring chemicals produced by
plants (terpenes) and can also be used with both natural and
synthetic compounds to enhance their performance and ease-of-use.
Sustaine microcapsules are naturally-derived, plastic-free,
biodegradable micro-spheres derived from yeast. It is one of the
only viable, proven and immediately registerable solutions to the
microplastics problem in formulations requiring encapsulation.
Eden has numerous patents and a pipeline of products at
differing stages of development targeting specific areas of the
global agrochemicals industry. Eden was admitted to trading on AIM
in May 2012.
For more information about Eden, please visit:
www.edenresearch.com .
ENDS
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ACSUAAARAVUBRAR
(END) Dow Jones Newswires
July 01, 2021 07:19 ET (11:19 GMT)
Eden Research (AQSE:EDEN.GB)
Historical Stock Chart
From Jun 2024 to Jul 2024
Eden Research (AQSE:EDEN.GB)
Historical Stock Chart
From Jul 2023 to Jul 2024